Login to Your Account



Durect Stock Falls 35 Percent On Likely Phase III Trial Delay

By Brady Huggett


Monday, October 20, 2003
No Abstract

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription